Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
185M
-
Number of holders
-
23
-
Total 13F shares, excl. options
-
2.42M
-
Shares change
-
-2M
-
Total reported value, excl. options
-
$26.2M
-
Value change
-
-$19.2M
-
Number of buys
-
19
-
Number of sells
-
-20
-
Price
-
$10.83
Significant Holders of HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) as of Q1 2021
40 filings reported holding AHAC - HUMACYTE, INC. - Common Stock, par value $0.0001 per share as of Q1 2021.
HUMACYTE, INC. - Common Stock, par value $0.0001 per share (AHAC) has 23 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.42M shares
of 185M outstanding shares and own 1.31% of the company stock.
Largest 10 shareholders include Tudor Investment Corp Et Al (543K shares), Alpine Global Management, LLC (521K shares), Maven Securities LTD (511K shares), UBS OCONNOR LLC (304K shares), Eversept Partners, LP (239K shares), MILLENNIUM MANAGEMENT LLC (46.5K shares), MARSHALL WACE, LLP (45.6K shares), BERKLEY W R CORP (41.8K shares), Newtyn Management, LLC (40.3K shares), and Verition Fund Management LLC (30K shares).
This table shows the top 23 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.